您所在的位置: 首页 --> 导师团队 --> 刘萌飞

导师基本信息

  • 姓名:刘萌飞
  • 性别:
  • 民族:汉族
  • 科室:遗传学研究室
  • 职称:副研究员
  • 专业:流行病与卫生统计学
  • E-MAIL: liumengfei1205@foxmail.com

学术论文 | 奖励表彰 | 科研项目 | 招生计划

Liu M#, Yang W#, Guo C#, Liu Z#, Li F, Liu A, Yang H, Shen L, Wu Q, Duan L, Wang H, Tian H, Shi C, Pan Y, Liu Y, Liu F, Weiss NS, Cai H, He Z*, Ke Y. Effectiveness of Endoscopic Screening on Esophageal Cancer Incidence and Mortality: A 9-Year Report of the Endoscopic Screening for Esophageal Cancer in China (ESECC) Randomized Trial.,J Clin Oncol,2024

Liu Z#, Liu M#, Liu Y#, Zhou R#, Abliz A#, Yuan W, Guo C, Zhang L, He W, Zheng H, Huang Y, Pan Y, Liu F, Hu Z, Chen H, Cai H, He Z*, Ke Y*. Absence of Lugol staining indicates initiation of esophageal squamous cell carcinoma: A combined genomic and epidemiologic study,Cell Rep Med,2023;4(9):101168.

Qin J#, Liu M#, Liu A#, Guo C, Qi Z, Zhou R, Yang H, Li F, Duan L, Shen L, Wu Q, Liu Z, Pan Y, Liu F, Liu Y, Cai H, He Z*, Ke Y*.Lugol-unstained lesions location in the esophagus affects the detection rate of malignancy: a population-based study.,J Gastroenterol Hepatol,2023;38(12):2167-2173.

Liu M#, Qi Z#, Zhou R#, Guo C, Liu A, Yang H, Li F, Duan L, Shen L, Wu Q, Liu Z, Pan Y, Liu F, Liu Y, Cai H, He Z*, Ke Y*.How should extra-large Lugol-unstained lesions of the esophagus be treated? Results from a population-based cohort study.,Cancer Med,2023;12(19):20129-20139.

Qi Z#, Liu M#, Zhou R, Guo C, Liu A, Yang H, Li F, Duan L, Shen L, Wu Q, Wu N, Liu Z, Pan Y, Liu F, Liu Y, Cai H, He Z*, Ke Y*.Multiple Lugol-unstained lesions predict higher cumulative risk of malignance in the esophagus.,J Gastroenterol Hepatol,2023.38(3):416-423.

Liu M#, Liu Y#, Zhou R#, Liu Z, Guo C, Xu R, Li F, Liu A, Yang H, Zhang S, Shen L, Duan L, Wu Q, Zhao M, Su H, Liu F, Pan Y, Cai H, He Z*, Ke Y*.Absence of NOTCH1 mutation and presence of CDKN2A deletion predict progression of esophageal lesions.,J Pathol.,2022.258(1):38-48.

Liu M#, Zhou R#, Liu Z#, Guo C, Xu R, Zhou F, Liu A, Yang H, Li F, Duan L, Shen L, Wu Q, Zheng H, Tian H, Liu F, Liu Y, Pan Y, Chen H, Hu Z, Cai H, He Z*, and Ke Y*. Update and validation of a diagnostic model to identify prevalent malignant lesions in esophagus in general population.,EClinicalMedicine,47:101394.

Liu M#, Zhou R#, Guo C, Xu R, Liu A, Yang H, Li F, Duan L, Shen L, Wu Q, Liu Z, Liu F, Liu Y, Pan Y, Cai H, Weiss NS*, He Z*, Ke Y*. Size of Lugol-unstained lesions as a predictor for risk of progression in premalignant lesions of the esophagus.,Gastrointest Endosc.,2021.S0016-5107(20)34785-4

Zhou R#, Zheng H#, Liu M#, Liu Z#, Guo C, Tian H, Liu F, Liu Y, Pan Y, Chen H, Hu Z, Cai H, He Z*, Ke Y*.Development and validation of a questionnaire-based risk scoring system to identify individuals at high risk for gastric cancer in Chinese populations.,Chin J Cancer Res,2021.33(6):649-658.

Wang M#, Liu M#, Guo C, Li F, Liu Z, Pan Y, Liu F, Liu Y, Bao H, Hu Z, Cai H, He Z*, Ke Y*.Association of early-life undernutrition and risk of dyslipidemia in adulthood: a population-based cohort study.,BMC Public Health,2021.21(1):2129.

Wang MM, Guo CH, Li FL, Xu RP, Liu Z, Pan YQ, Liu FF, Liu Y, Cai H, Liu MF*, He ZH, Ke Y*.Family history of esophageal cancer modifies the association of serum lipids and malignant esophageal lesions: a nested case-control study from the "Endoscopic Screening for Esophageal Cancer in China" trial.,Chin Med J (Engl),2021.134(9):1079-1086.

Liu F#, Liu M#, Liu Y#, Guo C, Zhou Y, Li F, Xu R, Liu Z, Deng Q, Li X, Zhang C, Pan Y, Ning T, Dong X, Hu Z, Bao H, Cai H, Silva IDS, He Z*, Ke Y*.Oral microbiome and risk of malignant esophageal lesions in a high-risk area of China: A nested case-control study.,Chin J Cancer Res,2020.32(6):742-754.

Wang M#, Liu M#, Li F, Guo C, Liu Z, Pan Y, Liu Y, Liu F, Cai H, Wu Y, He Z*, Ke Y*.Gender heterogeneity in dyslipidemia prevalence, trends with age and associated factors in middle age rural Chinese.,Lipids Health Dis,2020.19(1):135.

Liu M#, Liu Z#, Liu F#, Guo C, Xu R, Li F, Liu A, Yang H, Zhang S, Shen L, Duan L, Wu Q, Cao C, Pan Y, Liu Y, Li J, Cai H, He Z*, Ke Y*.Absence of Iodine Staining Associates With Progression of Esophageal Lesions in a Prospective Endoscopic Surveillance Study in China.,Clin Gastroenterol Hepatol,2020.18(7):1626-1635.

Shi C#, Liu M#, Liu Z, Guo C, Li F, Xu R, Liu F, Liu Y, Li J, Cai H, He Z*, Ke Y*.Using health insurance reimbursement data to identify incident cancer cases.,J Clin Epidemiol,2019.114:141-149.

2020年北京市科技新星计划, 北京市科技新星计划, 第1完成人, 北京大学医学部, 2021.9

食管癌前病变进展多组学预警标志物评估与预测模型构建, 课题负责人, 2022.1.1~2024.12.31, 北自然面上项目

基于人工智能技术建立食管癌碘染内镜筛查辅助诊断系统, 课题负责人, 2020.9.1~2023.8.31, 北京市科技新星

高发人群食管鳞癌癌前病变进展的风险预测与分级研究, 课题负责人, 2018.1.1~2021.12.31, 国自然面上项目

研究生招生计划
招生年度 招生专业 学位级别 学位类型 研究方向 选拔方式 操作
2025 流行病与卫生统计学 硕士 科学学位 肿瘤流行病学 推荐免试

社会任职

  • 中国抗癌协会食管癌整合防筛专业委员会 委员
  • 中国抗癌协会肿瘤病因学专业委员会 委员
  • 北京生物制品研究会肿瘤预防专业委员会 常委
  • 北京癌症防治学会精准预防专业委员会 委员

学习、工作经历

  • 2019.8.1~,北京大学, 北京大学肿瘤医院, 副研究员
  • 2015.8.1~2019.7.31,北京大学, 北京大学肿瘤医院, 助理研究员
  • 2014.6.1~2014.12.31,密歇根大学, 人类遗传学系, 访问学者
  • 2013.10.1~2014.1.31,爱因斯坦医学院, 生物统计学系, 访问学者
  • 2010.9.1~2015.7.1,北京大学, 肿瘤学, 博士